APGI Collaborators

The APGI central project illustrates an integrated and networked approach to a global effort dedicated to improving outcomes for pancreatic cancer patients. We bring together pancreatic cancer clinicians and scientists in major hospitals and research facilities across Australia, and with our global links support collaboration in transnational Pancreatic Cancer Research.

We are supported in various ways by a number of strategic partners ranging from academic institutions, scientific specialty groups, philanthropic organisations, clinical bodies, translational research centres and professional associations. Our partners provide collaborative support and in-kind strategic, operational, scientific or technical assistance across a range of APGI activities. The impressive APGI collaborative network currently consists of:

Clinical Collaborators

 

Network Members

  • Venkateswar Addala, QIMR Berghofer Medical Research Institute, QLD
  • Lesley Andrews, Hereditary Cancer Clinic, Prince of Wales Hospital, NSW
  • Jenny Arena, Northern Sydney Cancer Centre, Royal North Shore Hospital, NSW
  • Mehreen Arshi, APGI Project Officer, Garvan Institute
  • Ray Asghari, Department of Medical Oncology, Bankstown Hospital, NSW
  • Mo Ballal, Department of Surgery, Fremantle Hospital, WA
  • Andrew Barbour,  Department of Surgery, Greenslopes Private Hospital, QLD
  • Mark Brooke-Smith, Department of Surgery, Flinders Medical Center, SA
  • Maria Beilin, Medical Research Network, St John of God Hospital Subiaco, WA
  • Andrew Biankin, University of Glasgow, UK
  • Tim Bruxner, University of QLD, Institute for Molecular Biosciences, QLD
  • Lorraine Chantrill,  Department of Medical Oncology, St Vincents Hospital, NSW
  • John Chen, Department of Surgery, Flinders Medical Center, SA
  • Venessa Chin, Personalised Cancer Therapeutics Group, Garvan Institute, NSW
  • Angela Chou, Personalised Cancer Therapeutics Group, Garvan Institute, NSW
  • Angelika Christ, University of QLD, Institute for Molecular Biosciences, QLD
  • Andrew Clouston, Envoi Pathology, QLD
  • Mark Cowley, Clinical Genomics, Garvan Institute, NSW
  • Amithabad Das, Department of Surgery, Bankstown Hospital, NSW
  • Ali Drury, Personalised Cancer Therapeutics, Garvan Institute, NSW
  • Krishna Epari, Department of Surgery, Fremantle Hospital, WA
  • Jonathan Fawcett, Department of Surgery, Princess Alexandra Hospital, QLD
  • David Fletcher, Department of Surgery, Fremantle Hospital, WA
  • Cindy Forest, Department of Anatomical Pathology, Fremantle Hospital, WA
  • Danielle Froio, Personalised Cancer Therapeutics, Garvan Institute, NSW
  • Anthony Gill, Garvan Institute, Department of Anatomical Pathology RNSH, NSW
  • Annabel Goodwin, Cancer Genetics Specialist, Chris O’Brien Lifehouse, NSW
  • Peter Grimison, Department of Medical Oncology, Chris O’Brien Lifehouse, NSW
  • Sean Grimmond, University of Melbourne, Center for Cancer Research, VIC
  • Michaal Hatzifotis, Department of Surgery, Princess Alexandra Hospital, QLD
  • David Hermann, Invasion and Metastasis, Garvan Institute, NSW
  • Hilda High, Sydney Cancer Genetics, NSW
  • Peter Hodgkinson, Department of Surgery, Princess Alexandra Hospital, QLD
  • Oliver Hofmann, Cancer Medicine, University of Melbourne, VIC
  • Oliver Holmes, QIMR Berghofer Medical Research Institute, QLD
  • Jeremy Humphris, Consultant Gastroenterologist, APGI, Garvan Institute, NSW
  • Kasim Ismail, Department of Anatomical Pathology, Liverpool Hospital, NSW
  • Amber Johns, Project Manager, APGI, Garvan Institute, NSW
  • Stephen Kazakoff, QIMR Berghofer Medical Research Institute, QLD
  • James Kench, Department of Anatomical Pathology, Royal Prince Alfred Hospital, NSW
  • Judy Kirk, Familial Cancer Service, Westmead Hospital, NSW
  • Vincent Lam, Department of Surgery, Westmead Hospital, NSW
  • Conrad Leonard, QIMR Berghofer Medical Research Institute, QLD
  • Patrick Martin, Envoi Pathology, QLD
  • Scott Mead, SEALS Genetics Laboratory, NSW
  • Neil Merrett, Department of Surgery & Discipline of Surgery, University of Western Sydney, NSW
  • Skye McKay, Genome.One, Garvan Institute, NSW
  • Duncan McLeod, Department of Anatomical Pathology, Westmead Hospital, NSW
  • Ashleigh Morgan, Personalised Cancer Therapeutics, Garvan Institute, NSW
  • Anubhav Mittal, Department of Surgery, Royal North Shore Hospital, NSW
  • Sanjay Mukhedkar, Department of Medical Oncology, Fremantle Hospital, WA
  • Pamela Mukhopadhyay, QIMR Berghofer Medical Research Institute, QLD
  • Adnan Nagrial, Crown Princess Mary Cancer Centre, Westmead Hospital, NSW
  • Felicity Newell, QIMR Berghofer Medical Research Institute, QLD
  • Nam Nguyen, Department of Gastroenterology, Royal Adelaide Hospital, SA
  • Mehrdad Nikfarjam, Department of Surgery, Austin Health, VIC
  • Katia Nones, Medical Genomics, QIMR Berghofer Medical Research Institute, QLD
  • Chelsie O’Connnor, Department of Radiation Oncology, Liverpool Hospital, NSW
  • Thomas O’Rourke, Department of Surgery, Princess Alexandra Hospital, QLD
  • Marina Pajic, Personalised Cancer Therapeutics, Garvan Institute, NSW
  • Virginia Papangelis, Flinders Medical Centre Tissue Bank, SA
  • Ann-Marie Patch, Medical Genomics, QIMR Berghofer Medical Research Institute, QLD
  • Nick Pavlakis, Department of Oncology, Royal North Shore Hospital, NSW
  • Darren Pavey, Department of Gastroenterology, Bankstown Hospital, NSW
  • John Pearson, Genome Informatics, QIMR Berghofer Medical Research Institute, QLD
  • Mark Pinese, Genomic Cancer Medicine, Garvan Institute, NSW
  • Andreia Pinho, Invasion and Metastasis Group, Garvan Institute, NSW
  • Andrew Ruszkiewicz, Gastroenterology Research Laboratory, Royal Adelaide Hospital , SA
  • Jaswinder Samra, Department of Surgery, Royal North Shore Hospital, NSW
  • Charbel Sandroussi,Department of Surgery, RPAH, NSW
  • Christopher Scarlett, School of Environmental and Life Sciences, University of Newcastle, NSW
  • Kellee Slater, Department of Surgery, Princess Alexandra Hospital, QLD
  • Alina Stoita, Department of Gastroenterology, St Vincent’s Hospital, NSW
  • Allan Spigelman, St Vincent’s Hereditary Cancer Clinic, St Vincent’s Hospital, NSW
  • Angela Steinmann, Personalised Cancer Therapeutics, Garvan Institute, NSW
  • Michael Texler, Department of Anatomical Pathology, Fremantle Hospital, WA
  • Paul Timpson, Invasion and Metastasis, Garvan Institute, NSW
  • Kathy Tucker, Hereditary Cancer Clinic, POWH, NSW
  • Claire Venin, Invasion and Metastasis, Garvan Institute, NSW
  • Nic Waddell, Medical Genmics, QIMR, QLD
  • Sean Warren, Invasion and Metastasis Group, Garvan Institute, NSW
  • Peter Wilson, University of Queensland, Institute for Molecular Bioscience, QLD
  • Scott Wood, QIMR Berghofer Medical Research Institute, QLD
  • Chris Worthley, Department of Surgery, Royal Adelaide Hospital, SA
  • Jianmin Wu, Cancer Bioinformatics, Garvan Institute, NSW
  • Christina Xu, QIMR Berghofer Medical Research Institute, QLD
  • Nik Zeps, Medical Research Network, St John of God Hospital Subiaco, WA

International Collaborators

Philanthropic Organisations